Back to results
US 2020/0390816 A1Published application
Methods for activation and expansion of natural killer cells and uses thereof
AssigneeBoard of Regents, The University of Texas System
InventorsLucilla Nassif Kerbauy, Elizabeth Shpall, Katy Rezvani
Life of this patent
Estimating the term…
Abstract
Provided herein are methods for pre-activating and expanding an isolated population of NK cells. Further provided herein are methods for the treatment of cancer by administering the pre-activated and expanded NK cells.
Claims75
An in vitro method for expanding natural killer (NK) cells comprising:
- (a) obtaining a population of NK cells;
- (b) pre-activating the population of NK cells in a pre-activation culture comprising an effective concentration of IL-12, IL-15, and IL-18 to obtain pre-activated NK cells;
- and
- (c) expanding the pre-activated NK cells in an expansion culture comprising artificial antigen presenting cells (aAPCs) expressing CD137 ligand, thereby producing expanded NK cells.
1 more element
Dependencies are inferred from the claim text.